The surveillance and diagnosis of hepatocellular carcinoma.
暂无分享,去创建一个
[1] Christos Christidis,et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C , 2005, Hepatology.
[2] T. Kuzuya,et al. Changes in the characteristics and survival rate of hepatocellular carcinoma from 1976 to 2000 , 2004, Cancer.
[3] G. Sanders,et al. Cost‐effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C , 2004, Alimentary pharmacology & therapeutics.
[4] M. Colombo,et al. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. , 2004, Gastroenterology.
[5] H. Aburatani,et al. Identification of Soluble NH2-Terminal Fragment of Glypican-3 as a Serological Marker for Early-Stage Hepatocellular Carcinoma , 2004, Cancer Research.
[6] Zhao-You Tang,et al. Randomized controlled trial of screening for hepatocellular carcinoma , 2004, Journal of Cancer Research and Clinical Oncology.
[7] D. Thabut,et al. Expression of Granzyme B in viral hepatitis in patients with ALPS , 2004, Hepatology.
[8] D. Thabut,et al. Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors , 2004, Clinical chemistry and laboratory medicine.
[9] L. Bolondi. Screening for hepatocellular carcinoma in cirrhosis. , 2003, Journal of hepatology.
[10] Carmen Ayuso,et al. MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: An explant correlation , 2003, Hepatology.
[11] S. Taylor-Robinson,et al. Liver microbubble transit time compared with histology and Child-Pugh score in diffuse liver disease: a cross sectional study , 2003, Gut.
[12] J. Marrero,et al. Des‐gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients , 2003, Hepatology.
[13] L. Rodrigo,et al. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis , 2003, Hepatology.
[14] V. Chen,et al. Screening for Hepatocellular Carcinoma in Patients With Hepatitis C Cirrhosis: A Cost-Utility Analysis , 2003, American Journal of Gastroenterology.
[15] J. Heiken,et al. Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET. , 2003, Radiology.
[16] D. Treré,et al. Nucleolar hypertrophy correlates with hepatocellular carcinoma development in cirrhosis due to HBV infection , 2003, Hepatology.
[17] M. Colombo,et al. The natural history of hepatocellular carcinoma. , 2002, Toxicology.
[18] E. Bass,et al. Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: A systematic review , 2002, Hepatology.
[19] M. Zoli,et al. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience) , 2002, American Journal of Gastroenterology.
[20] N. Terrault,et al. Hepatitis C and hepatocellular carcinoma , 2001, Current treatment options in oncology.
[21] Jacques Ferlay,et al. Estimating the world cancer burden: Globocan 2000 , 2001, International journal of cancer.
[22] A. Morabito,et al. High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity , 2001, Hepatology.
[23] L Pagliaro,et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. , 2001, Journal of hepatology.
[24] A. Venook,et al. Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival , 2001, Hepatology.
[25] L. Qin,et al. Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma , 2001, Cancer.
[26] T. Poynard,et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study , 2001, The Lancet.
[27] M. Sherman,et al. Alphafetoprotein: an obituary. , 2001, Journal of hepatology.
[28] M. Bernardi,et al. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. , 2001, Journal of hepatology.
[29] M. Sherman,et al. Staging of hepatocellular carcinoma using the clip protocol , 2001 .
[30] M. Sherman,et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis , 2001, Gut.
[31] M. Makuuchi,et al. Results of surgical and nonsurgical treatment for small‐sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan , 2000, Hepatology.
[32] B. McMahon,et al. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: A 16‐year population‐based study , 2000, Hepatology.
[33] J. Kaldor,et al. Primary hepatocellular carcinoma in Australia, 1978‐1997: increasing incidence and mortality , 2000, The Medical journal of Australia.
[34] M. Schwartz,et al. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation , 2000, American Journal of Gastroenterology.
[35] R. Severino,et al. Improved survival with screening for hepatocellular carcinoma , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[36] I. Lauder,et al. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience , 2000, Hepatology.
[37] B. Choi,et al. Vascularity of hepatocellular carcinoma: assessment with contrast-enhanced second-harmonic versus conventional power Doppler US. , 2000, Radiology.
[38] J. Bruix,et al. Intention‐to‐treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation , 1999, Hepatology.
[39] S. Chevret,et al. Hepatocellular carcinoma without cirrhosis in the West: epidemiological factors and histopathology of the non-tumorous liver. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire. , 1999, Journal of hepatology.
[40] C. Frazer. Imaging of hepatocellular carcinoma , 1999, Journal of gastroenterology and hepatology.
[41] N. Chalasani,et al. Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey , 1999, American Journal of Gastroenterology.
[42] T. Joh,et al. Limitations of imaging diagnosis for small hepatocellular carcinoma: Comparison with histological findings , 1999, Journal of gastroenterology and hepatology.
[43] H. El‐Serag,et al. Rising Incidence of Hepatocellular Carcinoma in the United States , 1999, Infection Control & Hospital Epidemiology.
[44] H. El‐Serag,et al. Rising incidence of hepatocellular carcinoma in the United States. , 1999, The New England journal of medicine.
[45] F. Izzo,et al. Soluble Interleukin-2 Receptor Levels in Hepatocellular Cancer: a More Sensitive Marker Than Alfa Fetoprotein , 1999, Annals of Surgical Oncology.
[46] R. G. Parrish,et al. Hemochromatosis-Associated Mortality in the United States from 1979 to 1992: An Analysis of Multiple-Cause Mortality Data , 1998, Annals of Internal Medicine.
[47] D. Treré,et al. Preneoplastic cellular changes in liver , 1998, Hepatology.
[48] F. Izzo,et al. Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis. , 1998, Annals of surgery.
[49] P. Badrinath,et al. Trends in primary liver cancer , 1998, The Lancet.
[50] H. Thomas,et al. Increase in primary liver cancer in the UK, 1979–94 , 1997, The Lancet.
[51] J. Tsai,et al. Urinary transforming growth factor β1 levels in hepatitis C virus‐related chronic liver disease: Correlation between high levels and severity of disease , 1997 .
[52] A. Bhalla,et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. , 1997, Gastroenterology.
[53] J. Bruix,et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. , 1996, Gastroenterology.
[54] F. Sarasin,et al. Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis. , 1996, The American journal of medicine.
[55] M. Roncalli,et al. Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study. , 1995, Gastroenterology.
[56] A. Miller. An epidemiological perspective on cancer screening. , 1995, Clinical biochemistry.
[57] A. Bisceglie,et al. Hepatitis C and Hepatocellular Carcinoma , 1995, Seminars in liver disease.
[58] H. Tsukuma,et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. , 1993, The New England journal of medicine.
[59] P. Prorok. Epidemiologic Approach for Cancer Screening: Problems in Design and Analysis of Trials , 1992, The American journal of pediatric hematology/oncology.
[60] J. Bruix,et al. Natural history of hepatocellular carcinoma in Spain. Five year's experience in 249 cases. , 1990, Journal of hepatology.
[61] J. Hoofnagle,et al. Elevations in serum alpha‐fetoprotein levels in patients with chronic hepatitis B , 1989, Cancer.
[62] A. Lok,et al. α‐fetoprotein monitoring in chinese patients with chronic hepatitis B virus infection: Role in the early detection of hepatocellular carcinoma , 1989, Hepatology.
[63] M. Yamaguchi,et al. Relative risks of death due to liver disease among Japanese male adults having various statuses for hepatitis B s and e antigen/antibody in serum: A prospective study , 1988, Hepatology.
[64] H. Hsu,et al. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. , 1985, Gastroenterology.
[65] H. Hsu,et al. Early detection of hepatocellular carcinoma by real‐time ultrasonography. A prospective study , 1985, Cancer.
[66] N. Nagasue,et al. Serum levels of estrogens and testosterone in cirrhotic men with and without hepatocellular carcinoma. , 1985, Gastroenterology.
[67] C. Vogel,et al. Liver cell dysplasia: a premalignant condition , 1973, Journal of clinical pathology.
[68] F. I. Lee,et al. Cirrhosis and hepatoma in alcoholics. , 1966, Gut.
[69] T. Murakami,et al. Hepatocellular carcinoma: multidetector row helical CT , 2002, Abdominal Imaging.
[70] F. X. Bosch,et al. Epidemiology of Primary Liver Cancer , 1999, Seminars in liver disease.